ICD-10 Coding for Basal Cell Skin Cancer(C44.00, C44.22, C44.22B)
Comprehensive guide to ICD-10 coding for basal cell skin cancer, including site-specific codes, documentation requirements, and Mohs surgery billing.
Complete code families applicable to Basal Cell Skin Cancer
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C44.311 | Basal cell carcinoma of skin of nose | Use when basal cell carcinoma is confirmed on the skin of the nose. |
|
| C44.22 | Basal cell carcinoma of skin of ear and external auditory canal | Use when basal cell carcinoma is confirmed on the skin of the ear. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutBasal Cell Skin Cancer
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Basal Cell Skin Cancer.
Failing to document laterality for lesions on paired organs.
Impact
Clinical: May lead to incorrect treatment planning., Regulatory: Increases risk of non-compliance with coding standards., Financial: Potential for claim denials.
Mitigation
Always document right or left for lesions on paired organs., Use templates that prompt for laterality.
Using unspecified codes when specific site codes are available.
Impact
Reimbursement: May lead to lower reimbursement rates., Compliance: Increases risk of audit due to lack of specificity., Data Quality: Reduces accuracy of clinical data.
Mitigation
Always document and code the specific anatomical site of the basal cell carcinoma.
Use of unspecified codes
Impact
Frequent use of unspecified codes can trigger audits.
Mitigation
Document specific site and laterality to use specific codes.